Prevention and control of influenza recommendations of the Immunization Practices Advisory Committee (ACIP).
D000293:Adolescent; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control; D005260:Female; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007223:Infant; D009980:Influenza A virus; D009981:Influenza B virus; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D007251:Influenza, Human / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D012299:Rimantadine / Q000627:therapeutic use
D007252:Influenza Vaccines; D012299:Rimantadine; D000547:Amantadine